Inventor · disambiguated record
Haomin Huang
Also filed as: HUANG HAOMIN
11 granted patents·13 pending applications·23 citations·filing 2018–2024
84Inventor score
Files withSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD19SONNET BIOTHERAPEUTICS INC2MIDEA GROUP CO LTD1SHENYANG SUNSHINE PHARMACEUTICAL CO LTD1SONNET BIO THERAPEUTICS1
Top patents by PatentIndex Score
24 records- 0188US12269886B2Tetravalent bispecific antibody against PD-1 and PD-L1SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Granted Apr 8, 2025·2 cites·10 claims
- 0288US11028166B2Albumin binding domain fusion proteinsSONNET BIO THERAPEUTICS·Filed 2018·Granted Jun 8, 2021·7 cites·17 claims
- 0386USD1043734SElectronic device display screen with animated graphical user interfaceMIDEA GROUP CO LTD·Filed 2023·Granted Sep 24, 2024·11 cites·1 claims
- 0481US11667717B2Antibodies binding to human IL-4R, preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Jun 6, 2023·3 cites·12 claims
- 0577US2024309083A1Albumin binding domain fusion proteinsSONNET BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0671US12006361B2Albumin binding domain fusion proteinsSONNET BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 11, 2024·0 cites·5 claims
- 0770US2022127362A1Tetravalent bispecific antibody against pd-1/lag-3, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0870US2022127360A1Tetravalent bispecific antibody against pd-1 and vegf, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0970US2022127361A1TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/TGF-beta, PREPARATION METHOD THEREFOR, AND USE THEREOFSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1061US12509528B2Antibody binding to human CD38, preparation method thereof, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Granted Dec 30, 2025·0 cites·22 claims
- 1160US2024254232A1Trispecific antibody and preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1259US2025129175A1CDC Platform AntibodySUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1358US2025066499A1Antibody binding to human cd73, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1457US2022135686A1Antibody that binds to human pd-l1SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1557US2025066508A1Anti-masp-2 antibody, preparation method therefor, and application thereofSHENYANG SUNSHINE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1656US2023312682A1SIRPalpha-FC FUSION PROTEINSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1755US2022259330A1Tetravalent bispecific antibody, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1854US2023399394A1Antibody Binding to Human IL-33, Preparation Method Therefor, and Use ThereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1953US12351612B2Method for preparing recombinant human nerve growth factorSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·12 claims
- 2050US12319748B2Antibody binding to human HER2 and preparation method and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Jun 3, 2025·0 cites·18 claims
- 2150US11370836B2Monoclonal antibody binding to human IL-5, preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 28, 2022·0 cites·19 claims
- 2248US2023257465A1ANTI-PDL1 x EGFR BISPECIFIC ANTIBODYSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2343US11254746B2Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Feb 22, 2022·0 cites·23 claims
- 2442US12384853B2Anti-HER2/PD1 bispecific antibodySUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Aug 12, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Haomin Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →